Fundraising Fox
/Companies
Sign in

Caladan Bio

New York, US · Founded 2023 · Delaware corporation · 21 employees on LinkedIn · 6 known investors

Find your way into Caladan Bio

Sign up to find every way you can get introduced to Caladan Bio

  • Your email: who you already know at Caladan Bio, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Caladan Bio team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Caladan Bio develops high-throughput benchtop bioreactor hardware and software for laboratory bioprocessing, enabling faster experimentation and lower costs for biotech R&D teams. The company integrates bioreactor equipment with AI-driven process modeling software to support strain optimization and scale-up workflows.

AI & Machine LearningBiotechHardware

Founders & leadership

Caladan Bio was founded in 2023 by Michael Kobida and Rob Jauquet.

MKMichael Kobida
Michael KobidaCEO & Co-Founder
RJRob Jauquet
Rob JauquetCTO & Co-Founder

Investors · 6

Lerer Hippeaulisted by Lerer HippeauNew York · $500K – $2M

How we know: Lerer Hippeau's portfolio page · funding news · agfundernews.com · the VCSheet dataset · Not right? Tell us

Ritual Capitallisted by Ritual CapitalMenlo Park · $100K – $500Kvia Chris Howard · inferred

How we know: agfundernews.com · Not right? Tell us

Twelve Belowlisted by Twelve BelowNew York · $1M – $3M

How we know: funding news · agfundernews.com · the VCSheet dataset · Not right? Tell us

Wireframe Ventureslisted by Wireframe VenturesSan Francisco · $500K – $2M

How we know: Wireframe Ventures's portfolio page · funding news · agfundernews.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Factorial CapitalreportedBrooklyn · $500K

How we know: agfundernews.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$5.1M disclosed across 1 round · 2024

▶$5.1MraisedFeb 2024 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael J. KobidaExecutive Officer, Director
  • Robert JauquetExecutive Officer, Director
Offering amount
$5.1M
Amount sold
$5.1M
First sale
Feb 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Day One BiopharmaceuticalsDay One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Companies working in the same space as Caladan Bio.

Frequently asked questions

What does Caladan Bio do?
Caladan Bio develops high-throughput benchtop bioreactor hardware and software for laboratory bioprocessing, enabling faster experimentation and lower costs for biotech R&D teams. The company integrates bioreactor equipment with AI-driven process modeling software to support strain optimization and scale-up workflows.
Who founded Caladan Bio?
Caladan Bio was founded by Michael Kobida, Rob Jauquet in 2023.
Who are Caladan Bio's investors?
Caladan Bio's investors include Collaborative Fund, Lerer Hippeau, Ritual Capital, Twelve Below, Wireframe Ventures, Factorial Capital.
How much funding has Caladan Bio raised?
Caladan Bio has disclosed $5.1M raised across 1 round.
Where is Caladan Bio headquartered?
Caladan Bio is headquartered in New York, US.